123 related articles for article (PubMed ID: 8351957)
1. Normal calcitonin response to pentagastrin stimulation in patients with chronic renal failure.
Escalada J; Teruel JL; Pavón I; Vila T; Navarro J; Varela C
Acta Endocrinol (Copenh); 1993 Jul; 129(1):39-41. PubMed ID: 8351957
[TBL] [Abstract][Full Text] [Related]
2. Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis.
Niccoli P; Brunet P; Roubicek C; Roux F; Baudin E; Lejeune PJ; Berland Y; Conte-Devolx B
Eur J Endocrinol; 1995 Jan; 132(1):75-81. PubMed ID: 7850012
[TBL] [Abstract][Full Text] [Related]
3. Pentagastrin testing in patients with renal insufficiency: normal responsivity of mature calcitonin.
Lissak B; Baudin E; Cohen R; Barbot N; Meyrier A; Niccoli P; Bouyge N; Modigliani E
Thyroid; 1998 Mar; 8(3):265-8. PubMed ID: 9545114
[TBL] [Abstract][Full Text] [Related]
4. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
Messa P; Mioni G; Turrin D; Guerra UP
Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
[TBL] [Abstract][Full Text] [Related]
5. Low-dose calcium versus pentagastrin for stimulation of calcitonin in chronic hemodialysis patients: a pilot study.
Thiem U; Marculescu R; Cejka D; Gessl A; Borchhardt K
J Clin Endocrinol Metab; 2014 Dec; 99(12):4704-11. PubMed ID: 25215555
[TBL] [Abstract][Full Text] [Related]
6. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.
Brossard JH; Cloutier M; Roy L; Lepage R; Gascon-Barré M; D'Amour P
J Clin Endocrinol Metab; 1996 Nov; 81(11):3923-9. PubMed ID: 8923839
[TBL] [Abstract][Full Text] [Related]
8. Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism.
Lambert PW; Heath H; Sizemore GW
J Clin Invest; 1979 Apr; 63(4):602-8. PubMed ID: 438324
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
[TBL] [Abstract][Full Text] [Related]
10. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma.
Zink A; Blind E; Raue F
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858
[TBL] [Abstract][Full Text] [Related]
11. [Parathyrin and calcitonin in patients with chronic renal insufficiency].
Dzhavad-Zade MD; Agaev MM; Karaev ME
Med Radiol (Mosk); 1985 Dec; 30(12):47-9. PubMed ID: 4079692
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT.
Guilloteau D; Perdrisot R; Calmettes C; Baulieu JL; Lecomte P; Kaphan G; Milhaud G; Besnard JC; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1990 Oct; 71(4):1064-7. PubMed ID: 2401708
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma.
Perdrisot R; Bigorgne JC; Guilloteau D; Jallet P
Clin Chem; 1990 Feb; 36(2):381-3. PubMed ID: 2302785
[TBL] [Abstract][Full Text] [Related]
14. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of new assays for determination of serum calcitonin concentrations.
Weissel M; Kainz H; Tyl E; Ogunyemi E; Woloszczuk W
Acta Endocrinol (Copenh); 1991 May; 124(5):540-4. PubMed ID: 2028712
[TBL] [Abstract][Full Text] [Related]
16. Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults.
Doyle P; Düren C; Nerlich K; Verburg FA; Grelle I; Jahn H; Fassnacht M; Mäder U; Reiners C; Luster M
J Clin Endocrinol Metab; 2009 Aug; 94(8):2970-4. PubMed ID: 19491231
[TBL] [Abstract][Full Text] [Related]
17. Evidence that endogenous calcitonin protects against renal bone disease.
Kanis JA; Oliver D; Ledingham JC; Russell RG
Lancet; 1976 Dec; 2(7999):1322-6. PubMed ID: 63802
[TBL] [Abstract][Full Text] [Related]
18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
19. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma.
Kotzmann H; Schmidt A; Scheuba C; Kaserer K; Watschinger B; Söregi G; Niederle B; Vierhapper H
Thyroid; 1999 Sep; 9(9):943-7. PubMed ID: 10524574
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin in chronic renal failure.
Garancini S; Ballada L; Roncari G; Gastaldi L
Nephron; 1983; 34(4):224-7. PubMed ID: 6877457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
